urologytimes22 天
Study to inform definitive trial of 99mTc-sestaMIBI SPECT/CT for T1 renal tumors
The MULTI-MIBI study demonstrated feasibility in recruiting patients for Tc-sestaMIBI SPECT/CT trials for T1 renal tumors, enrolling 50 patients over 15 months. Tc-sestaMIBI SPECT/CT showed a ...
snmjournals.org27 天
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant ...
Journal of Nuclear Medicine November 2024, jnumed.124.267665; DOI: https://doi.org/10.2967/jnumed.124.267665 ...